Didanosine description: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Didanosine}} | {{Didanosine}} | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
==DESCRIPTION== | |||
VIDEX® is a brand name for didanosine, USP, a synthetic purine [[nucleoside]] analogue active against [[HIV-1]]. | |||
Didanosine is available as VIDEX, a Pediatric Powder for Oral Solution [see How Supplied/Storage and Handling (16)] and as VIDEX® EC Delayed-Release Capsules, containing enteric-coated beadlets. | |||
The chemical name for [[didanosine]] is 2′,3′-dideoxyinosine. The structural formula is: | |||
==References== | ==References== | ||
Revision as of 07:58, 1 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
DESCRIPTION
VIDEX® is a brand name for didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1.
Didanosine is available as VIDEX, a Pediatric Powder for Oral Solution [see How Supplied/Storage and Handling (16)] and as VIDEX® EC Delayed-Release Capsules, containing enteric-coated beadlets.
The chemical name for didanosine is 2′,3′-dideoxyinosine. The structural formula is:
References
Adapted from the FDA Package Insert.